Label: LORATADINE 10MG tablet

  • NDC Code(s): 25000-092-03, 25000-092-79, 25000-092-80, 25000-092-81
  • Packager: MARKSANS PHARMA LIMITED
  • Category: HUMAN OTC DRUG LABEL

Drug Label Information

Updated November 25, 2024

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

View All Sections
  • ACTIVE INGREDIENT(S)

    Active ingredient (in each tablet)
    Loratadine USP, 10 mg

  • PURPOSE

    Purpose 
    Antihistamine

  • USE(S)

    Uses
    temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

    • runny nose
    • itchy, watery eyes
    • sneezing 
    • itching of the nose or throat
  • WARNINGS

    Warnings

  • DO NOT USE

    Do not use if you have ever had an allergic reaction to this product or any of its ingredients.

  • ASK A DOCTOR BEFORE USE IF

    Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.

  • WHEN USING THIS PRODUCT

    When using this product do not take more than directed. Taking more than directed may cause drowsiness.

  • STOP USE AND ASK DOCTOR IF

    Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.

  • PREGNANCY/BREASTFEEDING

    If pregnant or breast-feeding, ask a health professional before use.

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222). 

  • DIRECTIONS

    Directions

    adults and children 6 years and over  1 tablet daily; not more than 1 tablet in 24 hours 
     children under 6 years of age ask a doctor
     consumers with liver or kidney disease ask a doctor



  • OTHER REQUIRED WARNINGS

    Other information

    • For Bottle pack: Tamper-evident: do not use this product if the imprinted foil seal over the mouth of the bottle is cut, torn, broken or missing.
    • For Blister pack: Tamper-evident: do not use if the individual blister unit is open or torn
    • store between 20º to 25º C (68º to 77º F)
    • FDA approved dissolution test specifications differ from USP
  • Inactive ingredients

    Inactive ingredients colloidal silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium starch glycolate

  • Questions or comments?

    Questions or comments? Call 1-877-376-4271 (weekdays 9 AM to 5 PM)

    Manufactured for:
    Time-Cap Labs, Inc. 
    7 Michael Avenue, 
    Farmingdale, 
    NY 11735

    Manufactured by: 
    Marksans Pharma Ltd.
    Plot No. L-82, L-83
    Verna Indl. Estate
    Verna, Goa-403722 

    Made in India

  • PRINCIPAL DISPLAY PANEL

    NDC: 25000-092-81
    Loratadine Tablets USP, 10 mg
    14's count Carton


    loratadine-tablets-14ct-blister-carton


    NDC: 25000-092-03
    Loratadine Tablets USP, 10 mg
    30's count Carton


    loratadine-tablets-30ct-carton


    NDC: 25000-092-03
    Loratadine Tablets USP, 10 mg
    30's count Label


    loratadine-tablets-30-ct-label


    NDC: 25000-092-79
    Loratadine Tablets USP, 10 mg
    150's count Carton


    loratadine-tablets-150ct-carton


    NDC: 25000-092-79
    Loratadine Tablets USP, 10 mg
    150's count Label


    loratadine-tablets-150ct-label


    NDC: 25000-092-80
    Loratadine Tablets USP, 10 mg
    365's count Label


    loratadine-tablets-365ct-label


  • INGREDIENTS AND APPEARANCE
    LORATADINE 10MG 
    loratadine 10mg tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:25000-092
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LORATADINE (UNII: 7AJO3BO7QN) (LORATADINE - UNII:7AJO3BO7QN) LORATADINE10 mg
    Inactive Ingredients
    Ingredient NameStrength
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MICROCRYSTALLINE CELLULOSE 101 (UNII: 7T9FYH5QMK)  
    SODIUM STARCH GLYCOLATE TYPE A (UNII: H8AV0SQX4D)  
    Product Characteristics
    ColorWHITE (White to off-white) Scoreno score
    ShapeROUNDSize6mm
    FlavorImprint Code 92
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:25000-092-031 in 1 CARTON11/21/2024
    130 in 1 BOTTLE; Type 0: Not a Combination Product
    2NDC:25000-092-791 in 1 CARTON11/21/2024
    2150 in 1 BOTTLE; Type 0: Not a Combination Product
    3NDC:25000-092-812 in 1 CARTON11/21/2024
    37 in 1 BLISTER PACK; Type 0: Not a Combination Product
    4NDC:25000-092-80365 in 1 BOTTLE; Type 0: Not a Combination Product11/21/2024
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA21922311/21/2024
    Labeler - MARKSANS PHARMA LIMITED (925822975)
    Establishment
    NameAddressID/FEIBusiness Operations
    MARKSANS PHARMA LIMITED925822975MANUFACTURE(25000-092)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials

More Info on this Drug

Get Label RSS Feed, View NDC Code(s)NEW!